Embla
Company

Last deal

$9M
Local Amount - EUR 10M

Amount

Series A

Stage

23.08.2023

Date

2

all rounds

$12.6M

Total amount

General

About Company
Embla offers an online medical weight loss treatment using prescription drugs.

Industry

Sector :

Subsector :

founded date

01.01.2021

Number of employees

Last funding type

Series A

IPO status

Private

Description

Founded in 2021 and based in Copenhagen, Denmark, Embla is a leading provider of evidence-based weight management solutions. Their comprehensive online platform combines digital tools, medication, and coaching to support sustainable weight loss. Embla's innovative approach, which includes the use of the latest GLP-1a-based medications, has quickly propelled them to become the market leader and top-rated provider in Denmark within just one year of operation.
Contacts

Phone number

Social url